Trials / Recruiting
RecruitingNCT04130789
Personalized Swiss Sepsis Study
Personalized Swiss Sepsis Study: With Machine Learning and Computational Modelling Towards Personalized Sepsis Management - Discovery of Digital Biomarkers
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 17,500 (estimated)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multi-center study is to focus on patients with sepsis in Intensive Care Units (ICUs) in order to better understand the complex host-pathogen interaction and clinical heterogeneity associated with sepsis. Understanding this heterogeneity may allow the development of novel diagnostic approaches. Data from patients will be analyzed using state-of-the art analytical algorithms for biomarker discovery including machine learning and multidimensional mathematical modelling to explore the large datasets generated. In order to discover digital biomarkers for the study endpoints a case-control study design will be used to compare data patterns from patients with sepsis (cases) and those without sepsis (controls).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | compare data patterns by data-driven algorithms to determine sepsis | compare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to reliably determine sepsis |
| OTHER | compare data patterns by data-driven algorithms to predict sepsis-related mortality | compare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to to predict sepsis-related mortality |
Timeline
- Start date
- 2019-11-15
- Primary completion
- 2022-05-31
- Completion
- 2025-12-01
- First posted
- 2019-10-17
- Last updated
- 2025-03-05
Locations
16 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04130789. Inclusion in this directory is not an endorsement.